These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24180745)

  • 81. Hemodynamics-Based Strategy of Using Retinoic Acid Receptor and Retinoid X Receptor Agonists to Induce MicroRNA-10a and Inhibit Atherosclerotic Lesion.
    Lee DY; Chiu JJ
    Methods Mol Biol; 2019; 2019():143-169. PubMed ID: 31359395
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
    Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
    Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
    Mirza Z; Beg MA
    Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
    Brooks SC; Kazmer S; Levin AA; Yen A
    Blood; 1996 Jan; 87(1):227-37. PubMed ID: 8547646
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Retinoid antagonists].
    Umemiya H; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
    Yakugaku Zasshi; 1996 Dec; 116(12):928-41. PubMed ID: 8993231
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity.
    Morishita K; Yakushiji N; Ohsawa F; Takamatsu K; Matsuura N; Makishima M; Kawahata M; Yamaguchi K; Tai A; Sasaki K; Kakuta H
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1001-3. PubMed ID: 19095448
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
    Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
    Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression.
    Volakakis N; Tiklova K; Decressac M; Papathanou M; Mattsson B; Gillberg L; Nobre A; Björklund A; Perlmann T
    J Neurosci; 2015 Oct; 35(42):14370-85. PubMed ID: 26490873
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Replacement of the hydrophobic part of 9-cis-retinoic acid with cyclic terpenoid moiety results in RXR-selective agonistic activity.
    Okitsu T; Sato K; Iwatsuka K; Sawada N; Nakagawa K; Okano T; Yamada S; Kakuta H; Wada A
    Bioorg Med Chem; 2011 May; 19(9):2939-49. PubMed ID: 21489804
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos.
    Luria A; Furlow JD
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8987-92. PubMed ID: 15178767
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A review of the molecular design and biological activities of RXR agonists.
    de Almeida NR; Conda-Sheridan M
    Med Res Rev; 2019 Jul; 39(4):1372-1397. PubMed ID: 30941786
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanism of the slow induction of apolipoprotein A-I synthesis by retinoids in cynomolgus hepatocytes: involvement of retinoic acid and retinoid X receptors.
    Kaptein A; Neele DM; Twisk J; Hendriks HF; Kooistra T; Princen HM
    J Lipid Res; 1997 Nov; 38(11):2273-80. PubMed ID: 9392425
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.
    Certo M; Endo Y; Ohta K; Sakurada S; Bagetta G; Amantea D
    Pharmacol Res; 2015 Dec; 102():298-307. PubMed ID: 26546745
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist.
    Gendimenico GJ; Stim TB; Corbo M; Janssen B; Mezick JA
    J Invest Dermatol; 1994 May; 102(5):676-80. PubMed ID: 8176247
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.
    Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH
    J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.
    le Maire A; Teyssier C; Balaguer P; Bourguet W; Germain P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694317
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
    Leal AS; Hung PY; Chowdhury AS; Liby KT
    Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.